OXURION NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 EUR | 0.00% |
|
-50.00% | -88.89% |
| 12/04 | Oxurion NV Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 06/03 | Oxurion Raises Additional Funds from Convertible Bonds Issue | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 620K | - | - | - | - | - | |
| 44.96B | - | |||||
| 42.65B | ||||||
| 41.85B | ||||||
| 29.04B | ||||||
| 26.08B |
- Stock Market
- Equities
- OXUR Stock
- Charts Oxurion NV
- Sector Chart
